Norges Bank
GBT

Norges Bank’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Norges Bank’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-960,504
Closed -$65.4M – 2214
2022
Q3 		$65.4M Buy
960,504
+387,709
+68% +$21.4M 0.02% 662
2022
Q2 		$18.3M Buy
572,795
+43,205
+8% +$1.26M ﹤0.01% 1287
2022
Q1 		$18.3M Buy
529,590
+327,469
+162% +$9.79M ﹤0.01% 1441
2021
Q4 		$5.92M Sell
202,121
-165,657
-45% -$5.13M ﹤0.01% 1891
2021
Q3 		$9.37M Hold
367,778
– – ﹤0.01% 1789
2021
Q2 		$12.9M Sell
367,778
-79,948
-18% -$3.12M ﹤0.01% 1705
2021
Q1 		$18.2M Sell
447,726
-106,558
-19% -$4.9M ﹤0.01% 1587
2020
Q4 		$24M Buy
554,284
+3,744
+0.7% +$185K 0.01% 1460
2020
Q3 		$30.4M Buy
550,540
+7,517
+1% +$478K 0.01% 1158
2020
Q2 		$34.3M Sell
543,023
-96,059
-15% -$6.59M 0.01% 1099
2020
Q1 		$32.7M Hold
639,082
– – 0.01% 933
2019
Q4 		$50.8M Buy
639,082
+13,190
+2% +$782K 0.01% 909
2019
Q3 		$30.4M Hold
625,892
– – 0.01% 1199
2019
Q2 		$32.9M Buy
625,892
+76,943
+14% +$4.42M 0.01% 1160
2019
Q1 		$29.1M Buy
548,949
+114,690
+26% +$5.64M 0.01% 1236
2018
Q4 		$17.8M Buy
434,259
+172,564
+66% +$6.47M 0.01% 1470
2018
Q3 		$9.95M Hold
261,695
– – ﹤0.01% 1820
2018
Q2 		$11.8M Buy
261,695
+11,087
+4% +$505K ﹤0.01% 1760
2018
Q1 		$12.1M Buy
+250,608
New +$14M ﹤0.01% 1679
2016
Q4 		– Sell
-48,600
Closed -$1.07M – 2177
2016
Q3 		$1.07M Sell
48,600
-11,400
-19% -$217K ﹤0.01% 2039
2016
Q2 		$995K Buy
+60,000
New +$1.21M ﹤0.01% 2066

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Norges Bank's GBT Position: Q4 2022 in Review

Norges Bank sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 960,504 shares — an estimated $65.4M sold.

Norges Bank first reported a position in GBT in Q2 2016 and held it in 21 quarters. The position peaked at $65.4M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Norges Bank reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Norges Bank sold 960,504 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $65.4M.
  • Norges Bank first reported a position in Global Blood Therapeutics, Inc. in Q2 2016 and held it in 21 quarters.
  • Norges Bank's Global Blood Therapeutics, Inc. position peaked at $65.4M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Norges Bank's 13F filing for Q4 2022, filed 14 Feb 2023.